Centers for Disease Control and Prevention (CDC). (2001). Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines. Morbidity and Mortality Weekly Report, 50(41), 889–893.
2.
ChinnK.S. (1996). Reaerosolization hazard assessment for biological agent-contaminated hardstand areas (Publication No. DPG/JCP-96/012). Life Sciences Division, Dugway Proving Ground, Utah: U.S. Dept. of Army, 1:40.
3.
ChristopherG.W.CieslakT.J.PavlinJ.A., & EitzenE.M. (1997). Biological warfare: A historical perspective. Journal of American Medical Association, 278(5), 412–417.
4.
FriedlanderA.WelkosS.L.PittM.L.EzzelJ.W.WorshamP.L.RoseK.J.IvinsB.E.LoweJ.R.HoweG.B., & MikesellP. (1993). Postexposure prophylaxis against experimental inhalation anthrax. Journal of Infectious Diseases, 167(5), 1239–1242.
5.
GwerderL.J.BeatonR., & DaniellW. (2001). Bioterrorism: Implications for the occupational and environmental health nurse. AAOHN Journal, 49(11), 512–518.
6.
InglesbyT.V.HendersonD.A.BartlettJ.G.AscherM.S.EitzenE.FriedlanderA.M.HauerJ.McDadeJ.OsterholmM.T.O'TooleT.ParkerG.PerlT.M.RussellP.K., & TonatK. (1999). Anthrax as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. Journal of American Medical Association. 283(15), 1963.
7.
IvinsB.E.FellowsP.PittM.L.M.EstepJ.E.WelkosS.L.WorshamP.L., & FriedlanderA.M. (1996). Efficacy of standard human anthrax vaccine against Bacillus anthracis aerosol spore challenges in the rhesus monkey. Salisbury Medical Bulletin, 87, 125–126.
8.
KahnA.S.LevittA.M., & SageM.J. (2001). Biological and chemical terrorism: Strategic plan for preparedness and response. Morbidity and Mortality Weekly Report, 49(RR04), 1–14.
9.
MeselsonM.GuilleminJ.Hugh-JonesM.LangmuirA.PopovaI.ShelokovA., & YampolskyaO. (1994). The Sverdlovsk anthrax outbreak of 1979. Science, 266(5188), 1202–1208.
10.
ZilinskasR.A. (1997). Iraq's biological weapons: The past as future?Journal of American Medical Association, 278(5), 418–424.